Related Experiment Videos

Synovial fluids from infected joints contain active metalloproteinases and no inhibitory activity

T E Cawston1, L Weaver, R J Coughlan

  • 1Rheumatology Research Unit, Addenbrooke's Hospital, Cambridge.

Insights

Septic arthritis involves active proteinases and a lack of inhibitors, leading to rapid cartilage damage. Treatment introduces proteinase inhibitors, reducing active enzymes in synovial fluid.

Area of Science:

  • Biochemistry
  • Rheumatology
  • Orthopedics

Background:

  • Septic arthritis causes rapid cartilage destruction.
  • The role of proteinases and inhibitors in this process is not fully understood.

Purpose of the Study:

  • To investigate the presence and activity of proteinases and their inhibitors in synovial fluid from septic arthritis patients.
  • To correlate enzyme activity with disease progression and treatment response.

Main Methods:

  • Serial synovial fluid samples were collected from two patients with septic arthritis.
  • Samples were analyzed for active metalloproteinases and proteinase inhibitors using biochemical assays.

Main Results:

  • Active metalloproteinases were detected in pre-treatment samples, with no detectable inhibitors.
  • Metalloproteinase levels decreased over time post-treatment, though proenzyme forms persisted.
  • Alpha 2-macroglobulin and tissue inhibitor of metalloproteinases were identified in post-treatment samples.

Conclusions:

  • The absence of inhibitors and presence of active proteinases contribute to cartilage degradation in septic arthritis.
  • Treatment initiation leads to the reappearance of proteinase inhibitors in synovial fluid.

Related Concept Videos